Target intelligence / Profile preview

Protein methionine and histidine residues

Molecular classification
Other
01

Overview

Protein methionine and histidine residues are specific amino acid side chains that play vital roles in protein structure, catalysis, and regulation. Methionine is a sulfur-containing amino acid that acts as a potent antioxidant by undergoing reversible oxidation to methionine sulfoxide, a process regulated by methionine sulfoxide reductases (MSRs) and involved in redox signaling (Vogt, 1995, Free Radic Biol Med; nih.gov). Histidine contains an imidazole side chain that is frequently found in enzyme active sites, where it participates in acid-base catalysis and coordinates essential metal ions such as zinc and copper (Che and Jones, 2022, RSC Med. Chem.). While these residues are not individual therapeutic targets, they serve as critical sites for the action of various drugs, including metal-based chemotherapeutics like cisplatin, which forms coordination complexes with both methionine and histidine (ResearchGate). Additionally, emerging covalent drug discovery efforts utilize electrophilic warheads to selectively target these residues in specific protein pockets to achieve irreversible inhibition (ACS Publications, 2026). For example, fumagillin and its derivatives target a specific histidine residue in methionine aminopeptidase 2 (MetAP2) to inhibit angiogenesis (ResearchGate). The broad distribution of these residues across the proteome poses significant challenges for drug selectivity and can lead to off-target toxicities (Levine et al., 1996, NIH).

Other names
Methionine and histidine side chainsMet and His residuesProtein-bound methionine and histidine
02

Mechanism of action

Covalent modification or coordination complex formation with the thioether group of methionine or the imidazole ring of histidine residues to modulate protein function or facilitate drug transport.

03

Biological functions

Metal coordinationAcid-base catalysisAntioxidant defenseRedox signalingProtein structural stabilization
04

Disease associations

CancerNeurodegenerative diseaseOxidative stress-related diseasesInflammation
05

Safety considerations

Off-target toxicity due to proteome-wide distributionPotential immunogenicity of modified proteinsNephrotoxicity and ototoxicity associated with non-specific metal bindingTherapeutic challenges in achieving site-specific selectivity
06

Interacting drugs

Cisplatin

5 more in the full profile.

07

Biomarkers

Methionine sulfoxide (MetO) levelsProtein-platinum adductsProtein carbonylationMethionine sulfoxide reductase (MSR) activity

Beyond the preview

Go deeper on Protein methionine and histidine residues.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein methionine and histidine residues.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call